Hot Arnaud, Jaisson Isabelle, Girard Charlotte, French Martine, Durand Denis Vital, Rousset Hugues, Ninet Jacques
Service de Médecine Interne, Hôpital Edouard Herriot, 5 Place d'Arsonval, 69437 Lyon CEDEX 03, France.
Arch Intern Med. 2009 Nov 23;169(21):2018-23. doi: 10.1001/archinternmed.2009.401.
Fever of unknown origin (FUO) still remains a diagnostic challenge, while diagnosis may remain obscure for several weeks or months. The role of tissue biopsy is crucial in the diagnostic approach. We report a series of 130 consecutive patients with FUO who had undergone a bone marrow biopsy (BMB).
Among 280 consecutive nonimmunocompromised patients hospitalized between 1995 and 2005 for a febrile illness of uncertain cause, lasting at least 3 weeks, with no diagnosis after an appropriate minimal diagnostic workup, 130 underwent BMB.
Overall, a specific diagnosis was achieved by BMB and histological examination in 31 cases (diagnostic yield, 23.7%). Three types of diseases were found: hematological malignant diseases in 25 cases, including 19 patients with malignant lymphoma, 4 with acute leukemia, 1 with hairy cell leukemia, and 1 with multiple myeloma; infectious diseases in 3 cases; systemic mastocytosis in 2 cases; and disseminated granulomatosis in 1 case. Thrombocytopenia (odds ratio, 4.9; 95% confidence interval, 1.04-9.30) and anemia (odds ratio, 3.24; 95% CI, 1.13-9.34) were the most reliable predictive factors regarding the usefulness of BMB. Bone marrow cultures had very limited value in our cohort. Finally, corticosteroid use did not seem to affect the yield of BMB.
Bone marrow biopsy is a useful technique for the diagnosis of prolonged fever in immunocompetent patients. Thrombocytopenia and anemia seem to be correlated with the value of this test.
不明原因发热(FUO)仍然是一个诊断难题,诊断可能在数周或数月内仍不明确。组织活检在诊断方法中起着关键作用。我们报告了连续130例接受骨髓活检(BMB)的FUO患者。
在1995年至2005年间因不明原因发热性疾病住院的280例连续非免疫功能低下患者中,疾病持续至少3周,经过适当的最小诊断检查后仍未确诊,其中130例接受了BMB。
总体而言,通过BMB和组织学检查在31例中获得了明确诊断(诊断率为23.7%)。发现了三种类型的疾病:血液系统恶性疾病25例,包括19例恶性淋巴瘤、4例急性白血病、1例毛细胞白血病和1例多发性骨髓瘤;传染病3例;系统性肥大细胞增多症2例;播散性肉芽肿病1例。血小板减少症(优势比,4.9;95%置信区间,1.04 - 9.30)和贫血(优势比,3.24;95%CI,1.13 - 9.34)是关于BMB有效性最可靠的预测因素。骨髓培养在我们的队列中价值非常有限。最后,使用皮质类固醇似乎不影响BMB的诊断率。
骨髓活检是诊断免疫功能正常患者长期发热的有用技术。血小板减少症和贫血似乎与该检查的价值相关。